Recent Incarceration Linked to Cutaneous Injection-Related Infections Among Active Injection Drug Users in a Canadian Setting
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Cutaneous injection-related infections (CIRI), such as abscesses and cellulitis, are the cause of a substantial burden of morbidity and mortality among injection drug users (IDU). The possible contribution of exposure to correctional environments to CIRI risk has not been fully investigated. Thus, we sought to test the possible relationship between incarceration and CIRI using data from a community-based sample of IDU. Data for these analyses was from the Scientific Evaluation of Supervised Injecting (SEOSI) cohort, linked with administrative records of a local ED in Vancouver, Canada. Using longitudinal analysis we assessed the relationship between the number of ED visits for CIRI care and recent incarceration in a multivariate model including information on possible confounders. Between June 2004 and December 2006, 901 individuals were eligible for our analysis. Of these, 214 (9.6%) visited the ED for CIRI care at least once during the study period. The incidence of ED care for CIRI was 72.9 per 100 person years. In a multivariate model, recent incarceration was associated with a greater number of ED visits for CIRI care (adjusted relative rate = 1.56, 95% confidence interval: 1.31–1.85, P < 0.001). The need for ED treatment for CIRI was common among a sample of local IDU. Exposure to correctional environments was an independent risk factor for visiting the ED for CIRI care, suggesting improvements in infection control in local prisons is urgently needed.
- Binswanger, I. A., Kral, A. H., Bluthenthal, R. N., Rybold, D. J., & Edlin, B. R. (2000). High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clinical Infectious Diseases, 30(3), 579–581. CrossRef
- Burkey, M. D., Wilson, L. E., Moore, R. D., Lucas, G. M., Francis, J., & Gebo, K. A. (2008). The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med, 9(10), 858–862.
- Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Montaner, J. S., & Kerr, T. H. (2008). Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC public health, 8(1), 405. CrossRef
- Bassetti, S., & Battegay, M. (2004). Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies. Infection, 32(3), 163–169. CrossRef
- Del Giudice, P. (2004). Cutaneous complications of intravenous drug abuse. British Journal of Dermatology, 150(1), 1–10. CrossRef
- From the Centers for Disease Control and Prevention. (2001). Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. JAMA, 285(21), 2707–2709. CrossRef
- Palepu, A., Tyndall, M. W., Leon, H., Muller, J., O’Shaughnessy, M. V., Schechter, M. T., et al. (2001). Hospital utilization and costs in a cohort of injection drug users. CMAJ, 165(4), 415–420.
- Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison—Mississippi, (2000). MMWR Morb Mortal Wkly Rep. 42:919–922.
- Methicillin-resistant Staphylococcus aureus infections in correctional facilities—Georgia, California, and Texas, (2001–2003). MMWR Morb Mortal Wkly Rep. 52(41):992–996.
- Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles County, California, (2002–2003). MMWR Morb Mortal Wkly Rep. 52(5):88.
- Wootton, S. H., Arnold, K., Hill, H. A., McAllister, S., Ray, M., Kellum, M., et al. (2004). Intervention to reduce the incidence of methicillin-resistant Staphylococcus aureus skin infections in a correctional facility in Georgia. Infection Control and Hospital Epidemiology, 25(5), 402–407. CrossRef
- Aiello, A. E., Lowy, F. D., Wright, L. N., & Larson, E. L. (2006). Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. The Lancet infectious diseases, 6(6), 335–341. CrossRef
- Buavirat, A., Page-Shafer, K., van Griensven, G. J., Mandel, J. S., Evans, J., Chuaratanaphong, J., et al. (2003). Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ, 326(7384), 308. CrossRef
- Milloy, M. J., Wood, E., Small, W., Tyndall, M., Lai, C., Montaner, J., et al. (2008). Incarceration experiences in a cohort of active injection drug users. Drug Alcohol Rev, 31, 1–7.
- Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., et al. (2007). Release from prison—a high risk of death for former inmates. New England Journal of Medicine, 356(2), 157–165. CrossRef
- Farrell, M., & Marsden, J. (2008). Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction, 103(2), 251–255. CrossRef
- Small, W., Wood, E., Lloyd-Smith, E., Tyndall, M., & Kerr, T. (2008). Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. Drug and Alcohol Dependence, 98(1–2), 159–162. CrossRef
- Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., et al. (2004). Methodology for evaluating Insite: Canada’s first medically supervised safer injection facility for injection drug users. Harm Reduct J, 1(1), 9. CrossRef
- Kerr, T., Wood, E., Grafstein, E., Ishida, T., Shannon, K., Lai, C., et al. (2005). High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health (Oxf), 27(1), 62–66. CrossRef
- Corneil, T. A., Kuyper, L. M., Shoveller, J., Hogg, R. S., Li, K., Spittal, P. M., et al. (2006). Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place, 12(1), 79–85. CrossRef
- Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005). Safer injection facility use and syringe sharing in injection drug users. Lancet, 366(9482), 316–318. CrossRef
- Wood, E., Tyndall, M. W., Li, K., Lloyd-Smith, E., Small, W., Montaner, J. S., et al. (2005). Do supervised injecting facilities attract higher-risk injection drug users? American Journal of Preventive Medicine, 29(2), 126–130. CrossRef
- Ver Hoef, J. M., & Boveng, P. L. (2008). Quasi-Poisson vs. negative binomial regression: How should we model overdispersed count data? Ecology, 88, 2766–2772. CrossRef
- Maldonado, G., & Greenland, S. (1993). Simulation study of confounder-selection strategies. American Journal of Epidemiology, 138(11), 923–936.
- Rothman, K. J., & Greenland, S. (1998). Modern Epidemiology. New York, NY: Lippincott Williams & Wilkins.
- Lima, V. D., Geller, J., Bangsberg, D. R., Patterson, T. L., Daniel, M., Kerr, T., et al. (2007). The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS, 21(9), 1175–1183. CrossRef
- Craven, D. E., Rixinger, A. I., Goularte, T. A., & McCabe, W. R. (1986). Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a “shooting gallery”. American Journal of Medicine, 80(5), 770–776. CrossRef
- Fleisch, F., Zbinden, R., Vanoli, C., & Ruef, C. (2001). Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clinical Infectious Diseases, 32(4), 581–586. CrossRef
- Young, D. M., Harris, H. W., Charlebois, E. D., Chambers, H., Campbell, A., Perdreau-Remington, F., et al. (2004). An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Archives of surgery (Chicago, Ill: 1960), 139(9), 947–951. (discussion 51–53).
- Gilbert, M., MacDonald, J., Gregson, D., Siushansian, J., Zhang, K., Elsayed, S., et al. (2006). Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Canadian Medical Association Journal, 175(2), 149–154. CrossRef
- Al-Rawahi, G. N., Schreader, A. G., Porter, S. D., Roscoe, D. L., Gustafson, R., & Bryce, E. A. (2008). Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. Journal of Clinical Microbiology, 46(2), 477–479. CrossRef
- Gilbert, M., MacDonald, J., Louie, M., Gregson, D., Zhang, K., Elsayed, S., et al. (2007). Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a marginalized urban population. The Canadian journal of infectious diseases & medical microbiology, 18(6), 357–362.
- Pan, E. S., Diep, B. A., Carleton, H. A., Charlebois, E. D., Sensabaugh, G. F., Haller, B. L., et al. (2003). Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clinical Infectious Diseases, 37(10), 1384–1388. CrossRef
- Binswanger, I. A., Takahashi, T. A., Bradley, K., Dellit, T. H., Benton, K. L., & Merrill, J. O. (2008). Drug users seeking emergency care for soft tissue infection at high risk for subsequent hospitalization and death. Journal of studies on alcohol and drugs, 69(6), 924–932.
- Matas, R. (2008). Inmates to be housed in tents at two B.C. jails. Globe and Mail. 15.
- Small, W., Kain, S., Laliberte, N., Schechter, M. T., O’Shaughnessy, M. V., & Spittal, P. M. (2005). Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Substance Use and Misuse, 40(6), 831–843. CrossRef
- Small, W., Wood, E., Betteridge, G., Montaner, J., Kerr, T. (2009). The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: A qualitative study. AIDS Care (in press).
- Barton-Forbes, M., Hawkes, M., & Moore, D. (2006). Guidelines for the prevention and management of community associated methicillin resistant Staphylococcus aureus (CA-MRSA): a perspective for Canadian health care practitioners. Canadian journal of infectious diseases and medical microbiology, 17, 1B–24B.
- Policy brief: Reduction of HIV transmission in prisons. Geneva, Switzerland: World Health Organization/UNAIDS/United Nations Office on Drugs and Crime 2005.
- The Dublin Declaration on HIV/AIDS in prisons in Europe and Central Asia. Dublin, Ireland: Irish Penal Reform Trust 2004.
- Medical Association. (2004). Improving our health: Why is Canada lagging behind in establishing needle exchange programs in prison?. Toronto, ON: Ontario Medical Association.
- Allen, U. D. (2006). Public health implications of MRSA in Canada. CMAJ, 175(2), 161.
- Chambers, H. F. (2005). Community-associated MRSA—resistance and virulence converge. New England Journal of Medicine, 352(14), 1485–1487. CrossRef
- Recent Incarceration Linked to Cutaneous Injection-Related Infections Among Active Injection Drug Users in a Canadian Setting
Journal of Community Health
Volume 35, Issue 6 , pp 660-666
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Injection drug use
- Cutaneous injection-related infection
- Emergency department
- Author Affiliations
- 1. British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada
- 2. School of Population and Public Health, University of British Columbia, Vancouver, Canada
- 5. Faculty of Medicine, University of British Columbia, Vancouver, Canada
- 3. Department of Infection Prevention and Control, Providence Health Care, Vancouver, Canada
- 4. Department of Emergency Medicine, St. Paul’s Hospital, Vancouver, Canada